The Future of Post-Brexit Regulation
As the UK prepares to leave the European Union, it will seek to cement itself as a world leader in the life sciences. This webinar was a launch event for a Reformer Thoughts publication exploring the practical challenges to overcome in medicines and medical device regulation to achieve this.
The publication covers topics from delivering a dynamic and responsive regulatory system, to using data and machine learning to support drug discovery and accelerate clinical trials. It has convened experts from several fields to discuss how the UK can realise its aims to become a global leader in medical innovation, through building the right regulatory environment.
Reform was delighted to hold this webinar, focusing on practical solutions to delivering a more effective regulatory system after Brexit.
- George Freeman MP, former Parliamentary Under Secretary of State for Life Sciences
- Jean Mchale, Director of the Centre for Health Law Science and Policy, University of Birmingham
- Emma du Four, Head of International Regulatory Policy and Intelligence, AbbVie
- Eleonora Harwich, Director of Research at Reform (Chair)
This event was held in collaboration with AbbVie.